Article
Licensed
Unlicensed
Requires Authentication
Nanomedicine translation from enabling technologies to the patient: focus on infectious diseases
-
Patrick Hunziker
Published/Copyright:
June 3, 2016
Published Online: 2016-6-3
Published in Print: 2016-7-1
©2016 by De Gruyter
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Frontmatter
- In this issue
- News
- CLINAM 2016 summit June 26–29, 2016
- Special section Nanotechnology for infectious diseases
- Editorial
- Nanomedicine translation from enabling technologies to the patient: focus on infectious diseases
- Critical Review
- Improving diagnosis of pneumococcal disease by multiparameter testing and micro/nanotechnologies
- Original Articles
- Solid lipid nanoparticles encapsulating a fluorescent marker (coumarin 6) and antimalarials – artemether and lumefantrine: evaluation of cellular uptake and antimalarial activity
- Nano-mupirocin: enabling the parenteral activity of mupirocin
- Regular contributions
- Review
- Radio-nanomaterials for biomedical applications: state of the art
Articles in the same Issue
- Frontmatter
- In this issue
- News
- CLINAM 2016 summit June 26–29, 2016
- Special section Nanotechnology for infectious diseases
- Editorial
- Nanomedicine translation from enabling technologies to the patient: focus on infectious diseases
- Critical Review
- Improving diagnosis of pneumococcal disease by multiparameter testing and micro/nanotechnologies
- Original Articles
- Solid lipid nanoparticles encapsulating a fluorescent marker (coumarin 6) and antimalarials – artemether and lumefantrine: evaluation of cellular uptake and antimalarial activity
- Nano-mupirocin: enabling the parenteral activity of mupirocin
- Regular contributions
- Review
- Radio-nanomaterials for biomedical applications: state of the art
